Article in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Unmesh J DesaiLeicester Institute for Pharmaceutical Innovation, Faculty of Health and Life Sciences, De Montfort University, The Gateway, Leicester LE1 9BH, UK.
M Joan TaylorLeicester Institute for Pharmaceutical Innovation, Faculty of Health and Life Sciences, De Montfort University, The Gateway, Leicester LE1 9BH, UK.
Sangeeta TannaLeicester Institute for Pharmaceutical Innovation, Faculty of Health and Life Sciences, De Montfort University, The Gateway, Leicester LE1 9BH, UK.ORCID 0000-0001-5246-3603
Neill HorleyLeicester Institute for Pharmaceutical Innovation, Faculty of Health and Life Sciences, De Montfort University, The Gateway, Leicester LE1 9BH, UK.ORCID 0000-0003-4563-6443
Mohsen SeifiLeicester Institute for Pharmaceutical Innovation, Faculty of Health and Life Sciences, De Montfort University, The Gateway, Leicester LE1 9BH, UK.ORCID 0000-0002-5795-4409
Raymond N AllanLeicester Institute for Pharmaceutical Innovation, Faculty of Health and Life Sciences, De Montfort University, The Gateway, Leicester LE1 9BH, UK.ORCID 0000-0001-7764-4849
Michal KozieleckiLeicester Institute for Pharmaceutical Innovation, Faculty of Health and Life Sciences, De Montfort University, The Gateway, Leicester LE1 9BH, UK.
Harprit SinghAllied Health Sciences, Faculty of Health and Life Sciences, De Montfort University, The Gateway, Leicester LE1 9BH, UK.ORCID 0000-0003-2337-3523
Dolgormaa JanchivlamdanAllied Health Sciences, Faculty of Health and Life Sciences, De Montfort University, The Gateway, Leicester LE1 9BH, UK.
Joseph FestaAllied Health Sciences, Faculty of Health and Life Sciences, De Montfort University, The Gateway, Leicester LE1 9BH, UK.ORCID 0000-0003-0355-3471
Andrew R BottrillProteomics Research Technology Platform, School of Life Sciences, University of Warwick, Gibbet Hill Road, Coventry CV4 7AL, UK.ORCID 0000-0002-5182-3643
Ahmed AlsabihDepartment of Physiology, College of Medicine, King Saud University, Riyadh 11461, Saudi Arabia.
Tarsem S SahotaLeicester Institute for Pharmaceutical Innovation, Faculty of Health and Life Sciences, De Montfort University, The Gateway, Leicester LE1 9BH, UK.ORCID 0000-0002-5510-1744
Funding
De Montfort University n/a
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
biologically active FITC-insulinFITCFITC-labelled insulinfluorescent labellinginsulin
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Synthesis and Characterisation of Bioactive Fluorescent FITC-Insulin Glulisine Conjugates for Potential Use in Insulin Delivery. · full record | OpenQuestion